{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T11:15:28Z","timestamp":1780658128963,"version":"3.54.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1995,5,1]],"date-time":"1995-05-01T00:00:00Z","timestamp":799286400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1995,5]]},"DOI":"10.1007\/bf02246153","type":"journal-article","created":{"date-parts":[[2005,11,15]],"date-time":"2005-11-15T05:04:26Z","timestamp":1132031066000},"page":"133-138","source":"Crossref","is-referenced-by-count":17,"title":["Olanzapine, an atypical antipsychotic, increases rates of punished responding in pigeons"],"prefix":"10.1007","volume":"119","author":[{"given":"Mark J.","family":"Benvenga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. David","family":"Leander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF02246153_CR1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1901\/jeab.1959.2-161","volume":"2","author":"N Azrin","year":"1959","unstructured":"Azrin N (1959) A technique for delivering shock to pigeons. J Exp Anal Behav 2:161\u2013163","journal-title":"J Exp Anal Behav"},{"key":"BF02246153_CR2","volume-title":"Target receptors for anxiolytic and hypnotics: from molecular pharmacology to therapeutics","author":"JE Barrett","year":"1992","unstructured":"Barrett JE (1992) Recent developments in animal models of anxiety and anxiolytic drugs. In: Mendlewicz J, Racagni G (eds) Target receptors for anxiolytic and hypnotics: from molecular pharmacology to therapeutics. Karger, Basel"},{"key":"BF02246153_CR3","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0091-3057(76)90080-0","volume":"5","author":"JE Barrett","year":"1976","unstructured":"Barrett JE, Witkin JM (1976) Interaction ofd-amphetamine with entobarbital and chlordiazepoxide: effects on punished responding behavior of pigeons. Pharmacol Biochem Behav 5:285\u2013292","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02246153_CR4","volume-title":"Buspirone: mechanisms and clinical aspects","author":"JE Barrett","year":"1988","unstructured":"Barrett JE, Witkin JM (1988) Buspirone in animal models of anxiety. In: Tunnicliff G, Eison AS, Taylor DP (eds) Buspirone: mechanisms and clinical aspects. Academic Press, New York"},{"key":"BF02246153_CR5","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/schbul\/14.2.297","volume":"14","author":"A Bleich","year":"1988","unstructured":"Bleich A, Brown S, Kahn R, Van Praag HM (1988) The role of serotonin in schizophrenia. Schizophr Bull 14:297\u2013315","journal-title":"Schizophr Bull"},{"key":"BF02246153_CR6","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00008877-199000150-00002","volume":"1","author":"MJ Brocco","year":"1990","unstructured":"Brocco MJ, Koek W, Degryse AD, Colpaert FC (1990) Comparative studies on the anti-punishment effects of chlordiazepoxide, buspirone and ritanserin in the pigeon, Geller-Seifter and ogel conflict procedures. Behav Pharmacol 1:403\u2013418","journal-title":"Behav Pharmacol"},{"key":"BF02246153_CR7","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(87)90101-5","volume":"8","author":"P Chopin","year":"1987","unstructured":"Chopin P, Briley M (1987) Animal models of anxiety: the effect of compounds that modify 5-HT neurotransmission. Trends Pharmacol Sci 8:383\u2013388","journal-title":"Trends Pharmacol Sci"},{"key":"BF02246153_CR8","first-page":"297","volume-title":"Schizophrenia research","author":"DM Coward","year":"1991","unstructured":"Coward DM (1991) Pharmacological approaches to the development of atypical antipsychotics. In: Tamminga CA, Schulz SC (eds) Schizophrenia research. Raven Press, New York, pp 297\u2013306"},{"key":"BF02246153_CR9","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1007\/BF00442552","volume":"99","author":"DM Coward","year":"1989","unstructured":"Coward DM, Imperato A, Urwyler S, White TG (1989) Biochemical and behavioral properties of clozapine. Psychopharmacology 99:S6-S12","journal-title":"Psychopharmacology"},{"key":"BF02246153_CR10","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.3854","volume":"192","author":"I Creese","year":"1976","unstructured":"Creese I, Burt DR, Snyder SH (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192:481\u2013483","journal-title":"Science"},{"key":"BF02246153_CR11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1055\/s-2007-1017385","volume":"18","author":"DLS Cuelemans","year":"1985","unstructured":"Cuelemans DLS, Hoppenbrouwers M, Gelders YG, Reyntjens AJM (1985) The influence of ritanserin, a serotonin antagonist, in anxiety disorders: a double-blind placebo-controlled study versus lorazepam. Pharmacopsychiatry 18:303\u2013305","journal-title":"Pharmacopsychiatry"},{"key":"BF02246153_CR12","first-page":"945","volume":"16","author":"B Ekblom","year":"1974","unstructured":"Ekblom B, Haggstrom JE (1974) Clozapine (Leponex) compared with chlorpromazine: a double-blind evaluation of pharmacological and clinical properties. Curr Ther Res 16:945\u2013957","journal-title":"Curr Ther Res"},{"key":"BF02246153_CR13","doi-asserted-by":"crossref","DOI":"10.1037\/10627-000","volume-title":"Schedules of reinforcement","author":"CB Ferster","year":"1957","unstructured":"Ferster CB, Skinner BF (1957) Schedules of reinforcement. Appleton Century-Crofts, New York"},{"key":"BF02246153_CR14","doi-asserted-by":"crossref","first-page":"722","DOI":"10.2165\/00003495-199040050-00007","volume":"40","author":"A Fitton","year":"1990","unstructured":"Fitton A, Heel RC (1990) Clozapine, a review of its pharmacological properties and therapeutic use in schizophrenia. Drugs 40:722\u2013747","journal-title":"Drugs"},{"key":"BF02246153_CR15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0014-2999(84)90695-2","volume":"106","author":"RL Friedman","year":"1985","unstructured":"Friedman RL, Sanders-Bush E, Barrett RJ (1985) Clozapine blocks disruptive and discriminative stimulus effects of quipazine. Eur J Pharmacol 106:191\u2013193","journal-title":"Eur J Pharmacol"},{"key":"BF02246153_CR16","first-page":"23","volume":"54","author":"RW Fuller","year":"1985","unstructured":"Fuller RW, Mason NR (1985) Flumezapine, an antagonist of central dopamine and serotonin receptors. Res Commun Chem Pathol Pharmacol 54:23\u201327","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"BF02246153_CR17","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/BF00429273","volume":"1","author":"I Geller","year":"1960","unstructured":"Geller I, Seifter J (1960) The effects of meprobamate, barbiturates,d-amphetamine and promazine on experimentally induced conflict in the rat. Psychopharmacologia 1:482\u2013492","journal-title":"Psychopharmacologia"},{"key":"BF02246153_CR18","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1600-0447.1974.tb09706.x","volume":"50","author":"J Gerlach","year":"1974","unstructured":"Gerlach J, Koppelhus E, Helweg E, Monrad A (1974) Clozapine and haloperidol in a single-blind cross-over trial: therapeutic and biochemical aspects in the treatment of schizophrenia. Acta Psychiatr Scand 50:410\u2013424","journal-title":"Acta Psychiatr Scand"},{"key":"BF02246153_CR19","first-page":"809","volume":"250","author":"S Gleeson","year":"1989","unstructured":"Gleeson S, Ahlers ST, Mansbach RS, Foust JM, Barrett JE (1989) Behavioral studies with anxiolytic drugs. VI. Effects on punished responding of drugs interacting with serotonin receptor subtypes. J Pharmacol Exp Ther 250:809\u2013817","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02246153_CR20","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1007\/BF00442551","volume":"99","author":"H Hippius","year":"1989","unstructured":"Hippius H (1989) The history of clozapine. Psychopharmacology 99:S3-S5","journal-title":"Psychopharmacology"},{"key":"BF02246153_CR21","first-page":"685","volume":"244","author":"PAJ Janssen","year":"1988","unstructured":"Janssen PAJ, Niemegeers CJE, Awouters F, Schellekens KHL, Megens AAHP, Meert TF (1988) Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties. J Pharmacol Exp Ther 244:685\u2013693","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02246153_CR22","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","volume":"45","author":"J Kane","year":"1988","unstructured":"Kane J, Honigfeld G, Singer J, Meltzer HY (1988) Clozapine for the treatment-resistent schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 45:789\u2013796","journal-title":"Arch Gen Psychiatry"},{"key":"BF02246153_CR23","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0149-7634(05)80056-9","volume":"16","author":"W Koek","year":"1992","unstructured":"Koek W, Jackson A, Colpaert FC (1992) Behavioral pharmacology of antagonists at 5-HT2\/5-HT1Creceptors. Neurosci Biobehav Rev 16:95\u2013105","journal-title":"Neurosci Biobehav Rev"},{"issue":"supp","key":"BF02246153_CR24","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1192\/S0007125000296906","volume":"160","author":"P Krupp","year":"1992","unstructured":"Krupp P, Barnes P (1992) Clozapine-associated agranulocytosis: risk and aetiology. Br J Psychiatry 160 [supp]:38\u201341","journal-title":"Br J Psychiatry"},{"key":"BF02246153_CR25","first-page":"114","volume":"246","author":"RS Mansbach","year":"1988","unstructured":"Mansbach RS, Harrod C, Hoffman SM, Nader MA, Lei Z, Witkin JM, Barrett JE (1988) Behavioral studies with anxiolytic drugs. V. Behavioral and in vivo neurochemical analyses in pigeons of drugs that increase punished responding. J Pharmacol Exp Ther 246:114\u2013120","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02246153_CR26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ddr.430180204","volume":"18","author":"TF Meert","year":"1989","unstructured":"Meert TF, Janssen PAJ (1989) Psychopharmacology of ritanserin: comparison with chlordiazepoxide. Drug Dev Res 18:119\u2013144","journal-title":"Drug Dev Res"},{"key":"BF02246153_CR27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/schbul\/2.1.19","volume":"2","author":"HY Meltzer","year":"1976","unstructured":"Meltzer HY, Stahl SM (1976) The dopamine hypothesis of schizophrenia: a review. Schizophr Bull 2:19\u201376","journal-title":"Schizophr Bull"},{"key":"BF02246153_CR28","first-page":"238","volume":"251","author":"HY Meltzer","year":"1989","unstructured":"Meltzer HY, Matsubara S, Lee JC (1989) Classification of typical and atypical drugs on the basis of dopamine D-1, D-2 and serotonin2. J Pharmacol Exp Ther 251:238\u2013246","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02246153_CR29","first-page":"545","volume":"262","author":"NA Moore","year":"1992","unstructured":"Moore NA, Tye NC, Axton MS, Risius FC (1992) The behavioral pharmacology of olanzapine, a novel \u201catypical\u201d antipsychotic agent. J Pharmacol Exp Ther. 262:545\u2013551","journal-title":"J Pharmacol Exp Ther."},{"key":"BF02246153_CR30","first-page":"281","volume":"2","author":"NA Moore","year":"1993","unstructured":"Moore NA, Calligaro DO, Wong DT, Bymaster F, Tye NC (1993) The pharmacology of olanzapine and other new antipsychotic agents. Curr Opin Inv Drugs, 2:281\u2013293","journal-title":"Curr Opin Inv Drugs"},{"key":"BF02246153_CR31","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/00008877-199404000-00011","volume":"5","author":"NA Moore","year":"1994","unstructured":"Moore NA, Rees G, Sanger G, Tye NC (1994) Effects of olanzapine and other antipsychotic agents on responding maintained by a conflict schedule. Behav Pharmacol 5:196\u2013202","journal-title":"Behav Pharmacol"},{"issue":"6","key":"BF02246153_CR32","first-page":"331","volume":"XIII","author":"M Mosconi","year":"1993","unstructured":"Mosconi M, Chiamulera C, Recchia G (1993) New anxiolytics in development. Int J Clin Pharm Res XIII[6]:331\u2013344","journal-title":"Int J Clin Pharm Res"},{"key":"BF02246153_CR33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0893-133X(88)90001-2","volume":"2","author":"K Rasmussen","year":"1988","unstructured":"Rasmussen K, Aghajanian GK (1988) Potency of antipsychotics in reversing the effects of a hallucinogenic drug on locus coeruleus neurons correlates with 5-HT2 binding affinity. Neuropychopharmacology 2:101\u2013107","journal-title":"Neuropychopharmacology"},{"key":"BF02246153_CR34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0091-3057(84)90137-0","volume":"21","author":"A Robertson","year":"1984","unstructured":"Robertson A, MacDonald C (1984) Atypical neuroleptics clozapine and thioridizine enhance amphetamine-induced stereotypy. Pharmacol Biochem Behav 21:97\u2013101","journal-title":"Pharmacol Biochem Behav"},{"key":"BF02246153_CR35","first-page":"39","volume":"1","author":"J Schmutz","year":"1982","unstructured":"Schmutz J, Eichenberger E (1982) Clozapine. Chronicles of Drug Discovery 1:39\u201359","journal-title":"Chronicles of Drug Discovery"},{"key":"BF02246153_CR36","volume-title":"Psychotropic drug side effects: chemical and theoretical perspectives","author":"RI Shader","year":"1970","unstructured":"Shader RI, Mascio A (1970) Psychotropic drug side effects: chemical and theoretical perspectives. Williams and Wilkins, Baltimore"},{"key":"BF02246153_CR37","first-page":"435","volume":"212","author":"RD Spealman","year":"1980","unstructured":"Spealman RD, Katz JL (1980) Some effects of clozapine on punished responding by mice and squirrel monkeys. J Pharmacol Exp Ther 212:435\u2013440","journal-title":"J Pharmacol Exp Ther"},{"key":"BF02246153_CR38","first-page":"603","volume":"26","author":"G Stille","year":"1971","unstructured":"Stille G, Lauener H, Eichenberger E. (1971) The pharmacology of 8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzoiazepine (clozapine). II Farmaco 26:603\u2013625","journal-title":"II Farmaco"},{"key":"BF02246153_CR39","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0091-3057(93)90237-N","volume":"45","author":"JL Wiley","year":"1993","unstructured":"Wiley JL, Compton AD, Porter JH (1993) Effects of four antipsychotics on punished responding in rats. Pharmacol Biochem Behav 45: 263\u2013267","journal-title":"Pharmacol Biochem Behav"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02246153.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02246153\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02246153","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T14:30:14Z","timestamp":1558017014000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02246153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,5]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1995,5]]}},"alternative-id":["BF02246153"],"URL":"https:\/\/doi.org\/10.1007\/bf02246153","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,5]]}}}